Author:
Rakhit Ashok,Holford Nicholas H. G.,Guentert Theodore W.,Maloney Kathy,Riegelman Sidney
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics
Reference14 articles.
1. C. T. Ueda, B. J. Williamson, and B. S. Dzinzio. Absolute quinidine bioavailability.Clin. Pharmacol. Ther. 20:260–265 (1976).
2. T. W. Guentert, N. H. G. Holford, P. E. Coates, R. A. Upton, and S. Riegelman. Quinidine pharmacokinetics in man: choice of a disposition model and absolute bioavailability studies.J. Pharmacokin. Biopharm. 7:315–330 (1979).
3. D. J. Greenblatt, H. J. Pfeifer, H. R. Ochs, D. S. Maclaughlin, T. W. Smith, and J. Koch-Weser. Pharmacokinetics of quinidine in humans after intravenous, intramuscular and oral administration.J. Pharmacol. Exp. Ther. 202:365–378 (1977).
4. D. E. Drayer, M. Hughes, B. Lorenzo, and M. M. Reidenberg. Prevalance of high (3S)-3-hydroxy quinidine/quinidine ratios in serum, and clearance of quinidine in cardiac patients with age.Clin. Pharmacol. Ther. 27:72–75 (1980).
5. N. H. G. Holford, P. E. Coates, T. W. Guentert, S. Riegelman, and L. B. Sheiner. The effect of quinidine and its metabolites on the electrocardiogram and systolic intervals.Br. J. Clin. Pharmacol. 11:187–195 (1981).
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献